Stocks and Investing
Stocks and Investing
Wed, March 1, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Bradley Canino Maintained (ZNTL) at Strong Buy with Decreased Target to $55 on, Mar 1st, 2023
Bradley Canino of Stifel, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy with Decreased Target from $58 to $55 on, Mar 1st, 2023.
Bradley has made no other calls on ZNTL in the last 4 months.
There are 5 other peers that have a rating on ZNTL. Out of the 5 peers that are also analyzing ZNTL, 0 agree with Bradley's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Bradley
- Robert Driscoll of "Wedbush" Maintained at Buy with Decreased Target to $32 on, Monday, November 14th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $55 on, Friday, November 11th, 2022
- Michael Schmidt of "Guggenheim" Maintained at Strong Buy with Decreased Target to $28 on, Friday, November 11th, 2022
- Andrew Berens of "SVB Leerink" Maintained at Buy with Decreased Target to $27 on, Thursday, November 10th, 2022
- Matthew Biegler of "Oppenheimer" Maintained at Buy with Decreased Target to $50 on, Thursday, November 10th, 2022
Contributing Sources